OPPM
ADMS
Opus Point Partners Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-44,500
| Closed | -$891K | – | 46 |
|
2018
Q3 | $891K | Buy |
44,500
+29,500
| +197% | +$591K | 2.13% | 20 |
|
2018
Q2 | $387K | Hold |
15,000
| – | – | 0.84% | 31 |
|
2018
Q1 | $359K | Sell |
15,000
-15,000
| -50% | -$359K | 0.7% | 32 |
|
2017
Q4 | $1.02M | Hold |
30,000
| – | – | 0.88% | 30 |
|
2017
Q3 | $635K | Hold |
30,000
| – | – | 0.57% | 36 |
|
2017
Q2 | $525K | Sell |
30,000
-30,000
| -50% | -$525K | 0.48% | 40 |
|
2017
Q1 | $1.05M | Hold |
60,000
| – | – | 0.78% | 31 |
|
2016
Q4 | $1.01M | Hold |
60,000
| – | – | 0.81% | 30 |
|
2016
Q3 | $985K | Buy |
60,000
+14,802
| +33% | +$243K | 0.55% | 29 |
|
2016
Q2 | $684K | Sell |
45,198
-8,802
| -16% | -$133K | 0.66% | 30 |
|
2016
Q1 | $781K | Sell |
54,000
-26,000
| -33% | -$376K | 0.6% | 35 |
|
2015
Q4 | $2.27M | Buy |
+80,000
| New | +$2.27M | 1.5% | 22 |
|